Carl Accettura

Carl Accettura is the Vice President & General Manager for PharmoRx Therapeutics, Inc., an emergent company, engaged in early stage development of novel therapy for the central nervous system, including Treatment Resistant Depression and Parkinson’s Disease.

Carl has 30 years of BioPharma industry experience with both Big Pharma - Pfizer, Roche, BMS – and Emergent Pharma companies - Anesta, Cephalon, Kyowa Hakko Kirin, Dainippon Sumitomo Pharma America, Sunovion, and Braeburn Pharmaceuticals.

Carl has held executive level (VP) positions in the areas of supply chain, new product development and operations. He has overseen the development of end-to-end supply chain strategies, operations, and product launches across the US, Europe and Asia.

Carl successfully launched major branded drugs (Procardia XL, Diflucan, Norvasc, Zithromax, Zoloft, Cardura, Actiq and Latuda) globally. He did this by ensuring advanced commercial readiness through effective global and regional regulatory filings and approvals. He founded a consulting firm, Global Pharma Consulting, which was established to support small and medium-sized companies commercialize Rx products.

Carl’s prior role was Vice President, Supply Chain at Braeburn Pharmaceuticals, where he developed the virtual supply chain for commercial launch readiness of a novel opioid implant product. He championed a novel trace and trace solution with partner, Covectra, for Probuphine’s strategic positioning as the “safest in the market”. He also developed the virtual supply chains at Anesta Pharmaceuticals, Kyowa Pharmaceuticals, and Dainippon Sumitomo Pharma America.

Carl’s subject matter expertise in pharmaceutical new product launch and supply chain management makes him a sought after speaker. He speaks each semester at the Cornell University Enterprise Engineering Seminar.

Carl earned a B.S. with distinction from Cornell University in Mechanical Engineering. He also holds a M.S. from University of Illinois and a M.B.A from the Stern School at New York University.